adagrasib
mirati
['lung', 'adagrasib']
lung cancer research at #asco22: non-small cell lung cancer's with kras mutation respond to experimenal drug adagrasib which also shows activity in brain metastasis. pasi janne, md, phd, is senior author. read more 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090